Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 5.

Blaes, J; Weiler, M; Sahm, F; Hentschel, B; Osswald, M; Czabanka, M; Thomé, C M; Schliesser, M G; Pusch, S; Luger, S; Winkler, F; Radbruch, A; Jugold, M; Simon, M; Steinbach, J P; Schackert, G; Tatagiba, M; Westphal, M; Tonn, J C; Gramatzki, D; Pietsch, T; Hartmann, C; Glimm, H; Vajkoczy, P; von Deimling, A; Platten, M; Weller, M; Wick, W (2014). NDRG1 prognosticates the natural course of disease in WHO grade II glioma. Journal of Neuro-Oncology, 117(1):25-32.

Weiler, M; Blaes, J; Pusch, S; Sahm, F; Czabanka, M; Luger, S; Bunse, L; Solecki, G; Eichwald, V; Jugold, M; Hodecker, S; Osswald, M; Meisner, C; Hielscher, T; Rübmann, P; Pfenning, P N; Ronellenfitsch, M; Kempf, T; Schnölzer, M; Abdollahi, A; Lang, F; Bendszus, M; von Deimling, A; Winkler, F; Weller, M; Vajkoczy, P; Platten, M; Wick, W (2014). mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy. Proceedings of the National Academy of Sciences of the United States of America, 111(1):409-414.

Berghoff, A S; Rajky, O; Winkler, F; Bartsch, R; Furtner, J; Hainfellner, J A; Goodman, S L; Weller, M; Schittenhelm, J; Preusser, M (2013). Invasion patterns in brain metastases of solid cancers. Neuro-Oncology, 15(12):1664-1672.

Wick, W; Winkler, F; Westphal, M; Weller, M (2012). Hirnmetastasen. In: Brandt, T; Diener, H C; Gerloff, C. Therapie und Verlauf neurologischer Erkrankungen. Stuttgart: Kohlhammer, 862-877.

Paul, R; Koedel, U; Winkler, F; Kieseier, B C; Fontana, A; Kopf, M; Hartung, H P; Pfister, H W (2003). Lack of IL-6 augments inflammatory response but decreases vascular permeability in bacterial meningitis. Brain : a journal of neurology, 126(8):1873-1882.

This list was generated on Sun Jun 16 14:59:56 2019 CEST.